A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

Stopped early · Phase 3

Conditions studied: Diabetes Mellitus

In brief

To assess the impact of inhalation of insulin on glucose disposition in patients with type 1 diabetes

Key facts

Study ID

NCT00287066

Run by

Pfizer

People needed

22

Starts

2006-02-01

Expected to finish

2007-03-01

Last updated by the study team

2008-02-21

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diabetes mellitus Type 1

You may not qualify if…

• Asthma, COPD
• Smoking

Where it is running

• Pfizer Investigational Site — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.